TARGET-EU: Clinical benefit of bevacizumab in metastatic colorectal cancer

11/05/2026
11/05/2026
EU PAS number:
EUPAS1000000996
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Emulation_Protocol_CS10_REV4_clean.pdf

English (839.43 KB - PDF) View document
Study results
Study report
Other information